CTSO logo

CTSO
Cytosorbents Corp

2,140
Mkt Cap
$38.58M
Volume
35,620.00
52W High
$1.39
52W Low
$0.4992
PE Ratio
-4.60
CTSO Fundamentals
Price
$0.6143
Prev Close
$0.61
Open
$0.64
50D MA
$0.6595
Beta
0.76
Avg. Volume
63,698.00
EPS (Annual)
-$0.1317
P/B
6.54
Rev/Employee
$287,310.08
$62.91
Loading...
Loading...
News
all
press releases
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights PR Newswire...
PR Newswire·2d ago
News Placeholder
More News
News Placeholder
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business...
PR Newswire·1mo ago
News Placeholder
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical...
PR Newswire·1mo ago
News Placeholder
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent...
PR Newswire·2mo ago
News Placeholder
What Analysts Are Saying About CytoSorbents Stock
read more...
Benzinga·4mo ago
News Placeholder
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and...
PR Newswire·4mo ago
News Placeholder
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday...
PR Newswire·5mo ago
News Placeholder
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London PR Newswire...
PR Newswire·6mo ago
News Placeholder
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update PR Newswire PRINCETON...
PR Newswire·6mo ago
News Placeholder
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London PR Newswire PRINCETON, N.J...
PR Newswire·6mo ago
<
1
2
...
>

Latest CTSO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.